Home Page / News / News Detail

Countdown 4d | What does Yeasen Biotechnology ’s booth look like at 2022 AACC?

Countdown 4 days, expect to see you 

2022 AACC is approaching. Yeasen expects to meet our biotech customers in Chicago. Welcome to Yeasen Biotechnologys booth at 2022 AACC. Focusing on the core raw materials of the life science industry, Yeasen is a biotechnology company engaged in the research and development, production and sales of three major categories of biological reagents: molecules, proteins and cells. Our Booth number is 4551. Yeasen provides enzyme raw materials for Basic Biological Research, Biopharmaceuticals and Vaccines, and Diagnostic Tests. Enzyme is our main business. Yeasen also covers products related to IVD, PCR, NGS, mRNA, Protein, Antibody etc. More than 300 products from various product lines are listed on our website. You can also inquire for any products you are interested in or leave a message for us. You can also contact us by sending us emails: overseas@yeasen.com.

Fig1. Front poster


Success in China

From the Independent Research Report on Global and ChinaBiological Reagent Market conducted by Frost & Sullivan Consulting Company on April 2022, you can see Yeasen s high ranking and successful stories to know more about us.

Success in China:

No.2 in Biological reagent scientific research institutions user market

No.3 in Molecular diagnostic raw materials enzymes market

No.2 in NGS library preparation raw materials enzymes and reagents market

No.3 in mRNA vaccine core enzyme raw material market

Fig2. Side poster 1 part 1

 2 large scale production factories

Moreover, Yeasen independently researched and developed more than 1,500 products, and served more than 23,000 clients and labs, and published thousands of scientific journals with accumulated 47,000 IF. Yeasen is professional because of its professional team. Trust Yeasen is your good choice. There are also 2 large scale production factories worth mentioning. One is Ultra Clean Molecular Enzyme factory (3,000 m2), which is equipped with advanced Ultra Clean Manufacture production line. Another one is ”mRNAtools” plant (50,000 m2), to produce GMP grade, large-batch enzymes as well as other auxiliary materials required for mRNA vaccine industry. We also have a video to introduce our ”mRNAtools”, please visit https://youtu.be/4rAVJf-8ABg Yeasen’s products are well-supplied, owing to our Ultra Clean Molecular Enzyme factory (UCF.ME) and “mRNAtools” factory, and are of high quality, conducted under the guideline of ISO13485 and with the GMP standards strictly followed.

Fig3. Side poster 1 part 2


6 core Platforms

Based on the common biotechnology in the field of life sciences such as genetic engineering technology, bioinformatics technology, cell biology technology, immunology technology, and biochemical analysis technology, Yeasen has established six core technology platforms.

They are:

1. Directed Evolution and Rational Design of Molecular Enzymes

2. High Density Protein Fermentation & Ultra-clean Protein Purification

3. Raw Materials R&D for Molecular Diagnostic testing

4. R&D for NGS Library Preparation Reagents

5. R&D for High-quality Monoclonal Antibody

6. Raw Materials R&D for mRNA Vaccine

Fig4. Side poster 2 part 1 


About Yeasen Biotechnology

Focusing on the core raw materials of the life science industry, Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company engaged in the research and development, production and sales of three major categories of biological reagents: molecules, proteins and cells. Yeasen has become an excellent high-tech enterprise in China, and has both independent R&D capabilities of core technologies of molecular enzymes, proteins, antibodies, nucleic acids, and cells, and large-scale production capabilities of related enzymes raw materials. Products are widely used in the field of life science research, diagnosis and detection, and biomedicine.